The Allergy and Respiratory Patients’ Digital Conference 2020 will feature in-depth presentations about digitalisation and innovation, to discuss their untapped potential to empower allergy and respiratory patients and improve healthcare outcomes.
Consisting of MEPs committed to policy actions addressing needs of allergy and asthma patients at EU level, the group is a policy forum to share expertise and align interests engaging with EU policymakers on allergy and asthma health.
3TR is an IMI funded project studying the molecular pathways and mechanisms linked to response and non-response to therapy in different immune-mediated, allergic and inflammatory diseases, including asthma and COPD.
More than 30 million Europeans live with asthma. CURE is an Horizon 2020 project that is testing if a phage therapy (virus) could control the immune dysregulation of asthma, and to eventually be able to cure it.
Every year on September 14th, EFA and the global community mark World Atopic Eczema Day, an opportunity to rise awareness about atopic eczema and improve understanding about the challenges it poses for people living with it.
#ShowLeadership is a pan-European campaign encouraging policymakers, stakeholders and individuals to take action to improve the situation of allergy, asthma and COPD patients in Europe. Only together, change is possible
Severely, ASTHMA! is a video series portraying six severe asthma patients and their families throughout Europe, each bringing a unique insight on diagnosis, care, social and family life, participating in research and living with air pollution.
EFA together with other 8 organisations launched a campaign for a European Parliament written declaration on respiratory diseases. We gathered 1 in 3 MEPs signing for the declaration, a clear signal the European Parliament wants more action in these diseases.
Show you care about patients, show leadership! EFA has issued a roadmap with concrete recommendations to improve the situation for people living with allergies and airways diseases in Europe.
The FoodDETECTives report puts a focus on the implementation of the EU Regulation on Food Information to Consumers and its provisions on food allergen labelling, and provides a set of recommendations on how to overcome legislative gaps.
The ACCESS report shows the realities of people with asthma and COPD in Europe. The report unveils the current access to diagnosis and care, and the involvement in prevention and care, based on a questionnaire to 774 patients in seven European countries.
Atopic eczema affects 3% of adults and 20% of children in the EU. This report encapsulates the results from the biggest-ever Quality of Life survey, and shakes the prevailing view on atopic eczema’s effects on patients.
The report is based on results of a survey that looked at the health status, asthma severity, attitude, treatment scheme, role of physicians and carers and health literacy of adolescents between 12-17 from France, Germany, Spain and UK.